Home > Insider Trading > Filing (0001415889-12-001655)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1374328	Bond Laboratories Inc.	BNLB.OB	Medicinal Chemicals & Botanical Products (2833)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1497703	S John Wilson	4509 S. 143Rd Street Suite 1 Omaha NE 68137	Chief Executive Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-11-06	1,399,352	$0.00	2,649,006	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Convertible Preferred Stock	Acquisiton	2012-11-06	9	$0.00	526,200	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
9			No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option	$0.10	2011-06-08	2021-06-08	500,000	500,000	Direct
Common Stock	Warrant	$0.15	2008-12-31	2013-12-31	1,000,000	1,000,000	Direct
Common Stock	Stock Option	$0.09	2012-05-09	2017-04-13	0	500,000	Direct
Common Stock	Series C Convertible Preferred Stock	$0.25			668,000	17	Direct
Common Stock	Warrant	$0.30		2015-11-15	332,500	332,500	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2021-06-08	500,000	500,000	Direct
2013-12-31	1,000,000	1,000,000	Direct
2017-04-13	0	500,000	Direct
	668,000	17	Direct
2015-11-15	332,500	332,500	Direct

Footnotes

Mr. Wilson acquired the shares of common stock, as well as the shares of Series B Convertible Preferred Stock reported in Table II ("Series B Preferred"), for aggregate consideration of $50,000, in a private transaction.
The Series B Preferred convert, without additional consideration, into shares of the Issuer's common stock on a 1-for-60,000 basis.
The Series B Preferred, Series C Convertible Preferred Stock ("Series C Preferred") and Warrants are immediately convertible, or exercisable, as the case may be.
The Series B Preferred and Series C Preferred are perpetual.
The Series C Preferred convert on a 1-for-40,000 basis.